@transgene.bsky.social is proud that our Chief Scientific Officer, #MaurizioCeppi, will join the 8th International Neoantigen Summit 2025 in Amsterdam in June.
His presentation will highlight the latest data related to our #individualized neoantigen cancer vaccine, #TG4050, from the myvac® platform.